Synthetic data in the clinical laboratory: methods, applications, and future prospects

Clinical laboratories face stringent privacy constraints, limited datasets for rare conditions, and rising demands to validate AI algorithms and workflows safely. Synthetic data-artificially generated data that preserve the statistical characteristics of real clinical data without exposing patient identities-has emerged as a powerful tool to address these challenges. This review provides a comprehensive overview of synthetic data in the context of laboratory medicine. We begin by defining synthetic data and describing the main generation methods, from rule-based simulations to modern generative models (including generative adversarial networks, variational autoencoders, and diffusion models) with examples of their use in healthcare. We then delve into key applications in the clinical laboratory: quality control and method validation, education and training, machine learning development, test utilization and workflow simulation, and external quality assessment. Advantages of synthetic data-such as enhanced privacy, scalability, flexibility in simulating rare events, and cost-effectiveness-are discussed with illustrative case studies. We also examine challenges and limitations, including concerns about data fidelity, bias amplification, risks of model overfitting or re-identification attacks, and the cautious stance of regulators that still require real patient data for approvals. Finally, we outline future directions for synthetic data in laboratory medicine, from hybrid real-synthetic datasets and privacy-enhancing techniques to evolving regulatory frameworks and the potential to democratize data access globally. While synthetic data cannot entirely replace real clinical data-especially for regulatory validation-it can significantly augment what laboratories can design, test, and achieve, provided it is used with careful validation and ethical safeguards.

Authors

Institutions

Publication Details

Journal
Clinica Chimica Acta
Published
2026-01-30
DOI
https://doi.org/10.1016/j.cca.2026.120878
Primary Topic
Privacy-Preserving Technologies in Data
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthetic data in the clinical laboratory: methods, applications, and future prospects

Chantal van Niekerk, Tahir S. Pillay, Siphokazi Gwiliza, Barbara Ströh van Deventer et al.
Clinica Chimica Acta
Privacy-Preserving Technologies in Data
article

Synthetic data in the clinical laboratory: methods, applications, and future prospects

Chantal van Niekerk, Tahir S. Pillay, Siphokazi Gwiliza, Barbara Ströh van Deventer, Evette L Subramoney
article en

Abstract

Clinical laboratories face stringent privacy constraints, limited datasets for rare conditions, and rising demands to validate AI algorithms and workflows safely. Synthetic data-artificially generated data that preserve the statistical characteristics of real clinical data without exposing patient identities-has emerged as a powerful tool to address these challenges. This review provides a comprehensive overview of synthetic data in the context of laboratory medicine. We begin by defining synthetic data and describing the main generation methods, from rule-based simulations to modern generative models (including generative adversarial networks, variational autoencoders, and diffusion models) with examples of their use in healthcare. We then delve into key applications in the clinical laboratory: quality control and method validation, education and training, machine learning development, test utilization and workflow simulation, and external quality assessment. Advantages of synthetic data-such as enhanced privacy, scalability, flexibility in simulating rare events, and cost-effectiveness-are discussed with illustrative case studies. We also examine challenges and limitations, including concerns about data fidelity, bias amplification, risks of model overfitting or re-identification attacks, and the cautious stance of regulators that still require real patient data for approvals. Finally, we outline future directions for synthetic data in laboratory medicine, from hybrid real-synthetic datasets and privacy-enhancing techniques to evolving regulatory frameworks and the potential to democratize data access globally. While synthetic data cannot entirely replace real clinical data-especially for regulatory validation-it can significantly augment what laboratories can design, test, and achieve, provided it is used with careful validation and ethical safeguards.

Clinica Chimica ActaVol. 585
National Health Laboratory Service (ZA), University of Pretoria (ZA)
Openalex Percentile: Top 74%
Privacy-Preserving Technologies in Data
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.